GALNT12 Polyclonal Antibody

Background:
This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer.

Synonyms:
Colorectal cancer susceptibility to 1, CRCS1, FLJ21212, GalNAc T12, GalNAc-T12, GalNAcT12, GALNT 12, Galnt12, GLT12, Polypeptide GalNAc transferase 12, Polypeptide N acetylgalactosaminyltransferase 12, Polypeptide N-acetylgalactosaminyltransferase 12, pp GaNTase 12, pp-GaNTase 12, Protein UDP acetylgalactosaminyltransferase 12, Protein-UDP acetylgalactosaminyltransferase 12, UDP GalNAc polypeptide N acetylgalactosaminyltransferase 12 , UDP GalNAc polypeptide N acetylgalactosaminyltransferase, UDP N acetyl alpha D galactosamine polypeptide N acetylgalactosaminyltransferase 12, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12

Immunogen: Fusion protein of human GALNT12

Swissprot: Q8IXK2
Gene Accession: BC013945

Purification Method: Antigen affinity purification

Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4

Concentration: 1.26 mg/mL
Dilution: IHC 1:50-1:300, ELISA 1:5000-1:10000

Storage:
Store at -20°C. Avoid freeze / thaw cycles.